Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Neovascular Glaucoma Global Clinical Trials Review, H1, 2015

Neovascular Glaucoma Global Clinical Trials Review, H1, 2015


  Request for Sample Report

Executive Summary

Neovascular Glaucoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Neovascular Glaucoma Global Clinical Trials Review, H1, 2015" provides data on the Neovascular Glaucoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neovascular Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neovascular Glaucoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Neovascular Glaucoma 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Neovascular Glaucoma 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Neovascular Glaucoma Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Gene Signal International SA 32

Clinical Trial Overview of Gene Signal International SA 32

ODIN Biotech Partners, LLC 33

Clinical Trial Overview of ODIN Biotech Partners, LLC 33

Clinical Trial Overview of Top Institutes / Government 34

Kumamoto University 34

Clinical Trial Overview of Kumamoto University 34

Federal University of Sao Paulo 35

Clinical Trial Overview of Federal University of Sao Paulo 35

University of Illinois 36

Clinical Trial Overview of University of Illinois 36

Shimane University 37

Clinical Trial Overview of Shimane University 37

Universidade Federal de Uberlandia 38

Clinical Trial Overview of Universidade Federal de Uberlandia 38

Hong Kong Eye Hospital 39

Clinical Trial Overview of Hong Kong Eye Hospital 39

University of Lubeck 40

Clinical Trial Overview of University of Lubeck 40

Faculty of Medicine Siriraj Hospital, Mahidol University 41

Clinical Trial Overview of Faculty of Medicine Siriraj Hospital, Mahidol University 41

Shahid Beheshti University of Medical Sciences 42

Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 42

Cairo University 43

Clinical Trial Overview of Cairo University 43

Five Key Clinical Profiles 44

Appendix 64

Abbreviations 64

Definitions 64

Research Methodology 65

Secondary Research 65

About GlobalData 66

Contact Us 66

Disclaimer 66

Source 66

List of Figures

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 65

List of Tables

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7

Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Neovascular Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Neovascular Glaucoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Neovascular Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Neovascular Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2015* 32

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ODIN Biotech Partners, LLC, 2015* 33

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2015* 34

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 35

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2015* 36

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 37

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal de Uberlandia, 2015* 38

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2015* 39

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Lubeck, 2015* 40

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of Medicine Siriraj Hospital, Mahidol University, 2015* 41

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 42

Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cairo University, 2015* 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Neovascular Glaucoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Neovascular Glaucoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com